The Jackson Laboratory

02/18/2026

The JAX-NYSCF Collaborative has announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer’s disease.

The collaboration reflects a strategic focus that brings together human stem cell research, advanced data science tools, and large-scale research systems to help close a long-standing gap between scientific discovery and the development of new medicines. The goal is to generate disease-relevant cellular models that enable the scientific community to interrogate the underlying human biology of neurodegenerative conditions such as Alzheimer’s disease and accelerate the translation of those insights into potential therapies.

Collaboration advances next-generation, human-relevant research tools to accelerate the development of treatments for Alzheimer’s disease and other neurodegenerative conditions

02/18/2026

Our partnerships — especially those with our generous donors — make us stronger. Read about the many ways that JAX supporters made a difference in 2025:
go.jax.org/impact2025

02/17/2026

To better understand diseases that develop toward the end of life, JAX Postdoctoral Associate Lauren Kuffler looks at the beginning. Read about how she's unlocking clues to aging by studying early development:

To better understand diseases that develop toward the end of life, Lauren Kuffler looks at the beginning.

02/14/2026

🌹 Roses are red, 💙 violets are blue, 💻 virtual hearts are important for me and you. Discover how AI-powered virtual hearts are reshaping drug safety testing this Valentine's Day. go.jax.org/cardioverse

02/13/2026

With an estimated 200 million cases worldwide, age-related macular degeneration (AMD) is the most common cause of vision loss in the aging population. JAX scientist Martin Pera is working to change the odds by engineering grafted cells that restore light-sensing cells in the eye, ultimately reversing vision loss related to AMD. Learn more:

A new gene therapy strategy underway at JAX could help reverse vision loss associated with age-related macular degeneration.

02/11/2026

Alzheimer’s disease is the sixth leading cause of death in the U.S., yet it is still poorly understood despite its huge cost and burden. We sat down with JAX Professor Greg Carter to talk about how he is using data and computational science to connect experimental models to real human disease.

Five questions with JAX Professor Greg Carter

02/06/2026

The appointments of three internationally recognized faculty to endowed chairs at The Jackson Laboratory will shape how diseases like cancer, Alzheimer’s disease and age-related immune decline are understood, detected and treated worldwide. Read more: https://bit.ly/3Mf2Mm3

Appointments highlight the value of data science and computational tools that accelerate discoveries in human health.

02/06/2026

Interested in seeing more about methylome profiling?

See our complementary piece with a short video and explore the topic further: https://www.jax.org/news-and-insights/2025/may/precision-brain-cancer-diagnosis

UConn Health, JAX partner to offer methylome profiling, enabling precision treatment

01/29/2026

🎉 🧬 Teaching the Genome Generation in action!

Congrats Mr. Linders and class for completing our curriculum, a program designed to provide high school teachers the content knowledge, teaching strategies, and resources needed to enhance student learning in genetics, genomics, and personalized medicine.

More information about our program is in the comments below.

01/23/2026

A new stem cell–based platform developed at The Jackson Laboratory (JAX) is shedding light on one of the biggest mysteries in genetics: Why the same disease-causing mutation can affect people in dramatically different ways—from severe symptoms to no symptoms at all.

Learn more: https://go.jax.org/stem-cells-autism

01/21/2026

When doctors diagnose a brain tumor, they often face a high-stakes mystery: Is it slow-growing and treatable or aggressive and terminal? But what if brain tumors could be more accurately diagnosed? Melissa Kelly and the JAX Advanced Precision Medicine Laboratory are changing the lives of patients through cutting-edge testing.

Learn more: https://www.jax.org/news-and-insights/2025/may/precision-brain-cancer-diagnosis

01/16/2026

Hour Newsroom recently published an article highlighting EndoRISE, a statewide initiative in Connecticut focused on advancing research, innovation, support, and education for those affected by endometriosis.

EndoRISE is striving to improve understanding of this complex and prevalent disease by expanding resources for patients, clinicians, and researchers.

The program is powered by minds and hearts from UConn Health and The Jackson Laboratory, including Elise Courtois, who co-leads the initiative and directs JAX’s Single Cell Biology Lab, and Caroline Haney, a JAX postdoctoral associate whose research centers on pain mechanisms in endometriosis. Their work, featured in the article and along with contributions from the broader JAX and UConn Health teams, is helping to build new scientific insight and deepen awareness of a condition that impacts millions.

Read it:

Despite its prevalence and complexity, the exact cause and biology of endometriosis is still not well understood.